These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 4628910)

  • 21. [Preparative separation of toxin and prototoxin from CL. botulinum type B cells].
    Ivanova LG; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):115-8. PubMed ID: 4218008
    [No Abstract]   [Full Text] [Related]  

  • 22. Tryptic activation of Clostridium botulinum type C beta toxin.
    Jansen BC; Knoetze PC
    Onderstepoort J Vet Res; 1971 Dec; 38(4):237-8. PubMed ID: 5164858
    [No Abstract]   [Full Text] [Related]  

  • 23. Acid precipitation of Clostridium botulinum type C and D toxins from whole culture by addition of ribonucleic acid as a precipitation aid.
    Iwasaki M; Sakaguchi G
    Infect Immun; 1978 Feb; 19(2):749-51. PubMed ID: 344224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autolytic enzyme system of Clostridium botulinum. I. Partial purification and characterization of an autolysin of Clostridium botulinum type A.
    Kawata T; Takumi K
    Jpn J Microbiol; 1971 Jan; 15(1):1-10. PubMed ID: 4927839
    [No Abstract]   [Full Text] [Related]  

  • 25. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alteration of the fractional composition and antigenic structure of botulin toxin E in the process of detoxication].
    Sycheva LP; Nemirovich-Danchenko MM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):117-20. PubMed ID: 4207091
    [No Abstract]   [Full Text] [Related]  

  • 27. [Gel filtration as a method of obtaining molecularly homogeneous bacterial toxins and anatoxins (a review of the literature)].
    Golshmid VK
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Dec; (12):89-96. PubMed ID: 4616559
    [No Abstract]   [Full Text] [Related]  

  • 28. [Some immunobiological properties of botulinum toxin C and its hemagglutinin-free fraction].
    Mierzejewski J; Bartoszcze M
    Med Dosw Mikrobiol; 1973; 25(3):223-9. PubMed ID: 4760225
    [No Abstract]   [Full Text] [Related]  

  • 29. Purification and characterization of heterologous component IIs of botulinum C2 toxin.
    Ohishi I; Hama Y
    Microbiol Immunol; 1992; 36(3):221-9. PubMed ID: 1376392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outbreaks of type C botulism in waterfowl in Japan.
    Ono T; Azuma R; Kato T; Takeuchi S; Suto T
    Natl Inst Anim Health Q (Tokyo); 1982; 22(3):102-14. PubMed ID: 6761593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Production of botulinum toxin in preserved fruits].
    de Lagarde A; Beerens H
    Ann Inst Pasteur Lille; 1970; 21():231-53. PubMed ID: 4948882
    [No Abstract]   [Full Text] [Related]  

  • 32. Behaviour of toxin released from the cells of Clostridium botulinum type E.
    Kitamura M
    Biochem Biophys Res Commun; 1970 Aug; 40(4):925-31. PubMed ID: 4993018
    [No Abstract]   [Full Text] [Related]  

  • 33. [Purification and characterization of botulinus toxin C].
    Sunagawa H; Inoue K
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):140. PubMed ID: 1240199
    [No Abstract]   [Full Text] [Related]  

  • 34. [Preparative isolation and immunochemical study of the O- and H-antigen components of Cl. botulinum types A and B].
    Ivanova LG; Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Dec; 46(12):51-8. PubMed ID: 4986278
    [No Abstract]   [Full Text] [Related]  

  • 35. [An immunochemical study of serologically active substances isolated from Cl. botulinum types A and B].
    Ivanova LG; Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):10-8. PubMed ID: 4969441
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of type A botulinal toxin assays that use antitoxin to crystalline toxin.
    Sugiyama H; Oishi I; Dasgupta BR
    Appl Microbiol; 1974 Feb; 27(2):333-6. PubMed ID: 4856714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium botulinum type C toxin: a sketch of the molecule.
    Syuto B; Kubo S
    Mol Cell Biochem; 1982 Oct; 48(1):25-32. PubMed ID: 6817077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Purification and Crystallization of Clostridium botulinum Type A Toxin.
    Lamanna C; McElroy OE; Eklund HW
    Science; 1946 May; 103(2681):613-4. PubMed ID: 17808402
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of botulinal hemagglutination.
    LOWENTHAL JP; LAMANNA C
    Am J Hyg; 1953 Jan; 57(1):46-59. PubMed ID: 13007684
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of the indirect hemagglutination method of detection of botulin toxins. Part I. Detection of botulin toxins type A and B with the aid of the indirect hemagglutination method (Rytsai modification)].
    SINITSYN VA
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Mar; 31():22-7. PubMed ID: 14447136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.